Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Other Non-Current Assets (2017 - 2025)

Dr Reddys Laboratories (RDY) has 6 years of Other Non-Current Assets data on record, last reported at $19.7 million in Q1 2024.

  • For Q1 2024, Other Non-Current Assets rose 96.52% year-over-year to $19.7 million; the TTM value through Mar 2024 reached $19.7 million, up 96.52%, while the annual FY2024 figure was $19.7 million, 97.15% up from the prior year.
  • Other Non-Current Assets reached $19.7 million in Q1 2024 per RDY's latest filing, up from $10.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $19.7 million in Q1 2024 and bottomed at $10.0 million in Q1 2023.
  • Average Other Non-Current Assets over 4 years is $13.3 million, with a median of $11.8 million recorded in 2020.
  • Peak YoY movement for Other Non-Current Assets: decreased 15.89% in 2023, then surged 96.52% in 2024.
  • A 4-year view of Other Non-Current Assets shows it stood at $11.7 million in 2020, then grew by 2.05% to $11.9 million in 2022, then decreased by 15.89% to $10.0 million in 2023, then soared by 96.52% to $19.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $19.7 million in Q1 2024, $10.0 million in Q1 2023, and $11.9 million in Q1 2022.